This page contains health-related information for reference only. It is not medical advice. Read full disclaimer
hair transplant
PRP for Hair Loss
Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is a concentrate of plasma protein derived from whole blood, centrifuged to remove red blood cells but retaining platelets. Though promoted for treating various medical conditions, evidence of its benefits was mixed as of 2020, showing effectiveness in certain conditions and ineffectiveness in others.
Quick Facts
- Recovery
- Varies
- Sessions
- Varies
- Category
- hair transplant
- Anaesthesia
- Varies
- Min. stay abroad
- Varies
- Average Recovery
- Varies
- Typical Sessions
- Varies
- Category
- hair transplant
Overview
Platelet-rich plasma (PRP) therapy for hair loss uses a concentrate of the patient's own platelets, prepared from their blood, and injected into the scalp to treat hair thinning. PRP, also known as autologous conditioned plasma, is a concentrate of plasma protein derived from whole blood that is centrifuged to remove red blood cells while retaining the platelets. Because platelets contain multiple growth factors and other cytokines that can stimulate the healing of soft tissues, PRP has been applied across several fields, including sports medicine and orthopaedics, dermatology and even proctology. In dermatology its uses include androgenic alopecia (pattern hair loss), wound healing and skin rejuvenation. Various preparation protocols exist, but the underlying principle is to concentrate platelets and then inject this concentrate into the tissue where healing or stimulation is desired, in this case the scalp. Because the plasma is drawn from the patient's own blood, PRP is autologous. It is important to note that the evidence for PRP is mixed: as of 2020 it had been shown to be effective for certain conditions and ineffective for others, so its benefit for hair loss should be understood in that context rather than as an established certainty.
A 2023 Blood Transfusion systematic review and meta-analysis of PRP for alopecia (AGA, androgenetic alopecia; AA, alopecia areata) reported: "We found 27 controlled trials (1,117 subjects) that met our inclusion criteria: 18 trials (713 subjects) in patients with AGA, and 9 (404 subjects) in patients with AA." It also reported: "There was heterogeneity in types of PRP (e.g., activated and non-activated) and administration schedules." "Compared to saline injections, PRP injections increased hair density over a medium-term follow-up (MD, 25.6 hairs/cm2; 95 % CI: 2.62-48.57), but the evidence was rated as low quality due to inconsistency and risk of bias." "In individuals with AA, it is unclear whether PRP injection compared with triamcinolone injection increase the rate of subjects with hair regrowth (very-low quality of evidence due to inconsistency, imprecision, and risk of bias)." "There were no serious adverse events related to PRP injection or control treatments." Its authors concluded: "There is limited evidence showing benefit of PRP for treatment of alopecia, and most of this evidence is of low quality."
A 2020 Journal of Cosmetic Dermatology systematic review of randomised trials of PRP in pattern hair loss reported: "We identified 13 relevant randomized controlled trials with 356 randomized (343 analyzed) people or half-head areas who received PRP in a simple parallel or half-head design." "Time point of outcome assessment was 6 months after start of treatment." It also reported: "The pooled data of seven studies (171 analyzed people or half-head areas) were favorable in the PRP group on hair density. We estimated a mean difference from baseline of 30.35 associated with a wide 95% confidence interval (1.77-58.93), a considerable heterogeneity (I2 = 100%), and unclear risk of bias in most of the studies." "We did not identify serious treatment-related adverse events."
A 2020 International Journal of Molecular Sciences systematic review of PRP in androgenic alopecia reported: "only 12 clinical trials were analyzed". It also reported: "In total, 84% of the studies reported a positive effect of PRP for AGA treatment. Among them, 50% of the studies demonstrated a statistically significant improvement using objective measures and 34% of the studies showed hair density and hair thickness improvement, although no p values or statistical analysis was described." "Only 17% of the studies reported that PRP was not effective in treating AGA."
A 2024 Journal of Cosmetic and Laser Therapy systematic review of treatments for androgenic alopecia reported: "We demonstrate that many over the counter (e.g. topical minoxidil, supplements, low-level light treatment), prescription (e.g. oral minoxidil, finasteride, dutasteride), and procedural (e.g. platelet-rich plasma, fractionated lasers, hair transplantation) treatments successfully promote hair growth"
Key Considerations
- A 2023 Blood Transfusion systematic review and meta-analysis of PRP for alopecia (AGA, androgenetic alopecia; AA, alopecia areata) concluded: "There is limited evidence showing benefit of PRP for treatment of alopecia, and most of this evidence is of low quality."
- A 2023 Blood Transfusion systematic review and meta-analysis of PRP for alopecia (AGA, androgenetic alopecia; AA, alopecia areata) reported: "There was heterogeneity in types of PRP (e.g., activated and non-activated) and administration schedules."
- A 2020 Journal of Cosmetic Dermatology systematic review of randomised trials of PRP in pattern hair loss reported: "Time point of outcome assessment was 6 months after start of treatment."
- A 2023 Blood Transfusion systematic review and meta-analysis of PRP for alopecia (AGA, androgenetic alopecia; AA, alopecia areata) reported: "In individuals with AA, it is unclear whether PRP injection compared with triamcinolone injection increase the rate of subjects with hair regrowth (very-low quality of evidence due to inconsistency, imprecision, and risk of bias)."
Compare with
Current clinical trials
Ongoing research studies registered on ClinicalTrials.gov whose intervention involves prp for hair loss. This is a neutral pointer to public research — not an endorsement, not a recruitment drive, and not medical advice. Trial status changes often; confirm eligibility and current status with the study team via each record.
- Not yet recruitingEARLY_Phase 1Interventional· Started 2026-12-30Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled TrialNCT07739147· Kimberly Meathrel· Androgenetic Alopecia
- Not yet recruitingEARLY_Phase 1Interventional· Started 2026-07Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic AlopeciaNCT03474718· Wake Forest University Health Sciences· Androgenic Alopecia
- RecruitingPhase 1/Phase 2Interventional· Started 2026-01-09Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia PatientsNCT07429253· PT. Prodia Stem Cell Indonesia· Androgenetic Alopecia
- RecruitingPhase 2Interventional· Started 2026-01-09PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A StudyNCT07335367· Nanfang Hospital, Southern Medical University· Androgenetic Alopecia (AGA)
- Not yet recruitingInterventional· Started 2026-01Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantationNCT07287579· Sohag University· Androgenic Alopecia
- Not yet recruitingInterventional· Started 2024-08-30Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic AlopeciaNCT06558565· Kasr El Aini Hospital· Androgenetic Alopecia
Showing 6 recent ongoing studies. Source: ClinicalTrials.gov — all matching trials (U.S. National Library of Medicine, public domain). Retrieved 2026-08-02.
Recovery Timeline
Average recovery for PRP for Hair Loss is 0 days. Individual recovery varies — always follow your surgeon’s specific guidance.
- 01Day 0–1
Immediate
First 24–48 hours post-procedure. Monitoring, anaesthesia recovery, initial pain management. Most clinics expect you to remain on-site or nearby.
- 02Day 2–2
Early recovery
Wound care, swelling or bruising peaks, restricted activity. Typical window for follow-up visits and drain removal if applicable. Travel is usually not advised.
- 03Day 3–3
Intermediate recovery
Gradual return to non-strenuous daily activity. Many international patients fly home during this window. Surgeon may require medical clearance for long-haul travel.
- 04Day 4–0
Full recovery
Return to full activity, exercise, and work. Final results may still be settling. Final follow-up with local doctor recommended.
Questions to Ask Your Clinic
- 01Which PRP preparation does the clinic use (activated or non-activated), and how many sessions are planned?
- 02Is the hair loss being treated androgenetic alopecia or another type?
- 03How does the clinic measure response, for example hair density, and at what time points?
Browse all destinations offering PRP for Hair Loss →
Frequently Asked Questions
What is PRP?
Platelet-rich plasma, or PRP, is a concentrate of plasma protein derived from a sample of the patient's whole blood, centrifuged to remove red blood cells while keeping the platelets. It is also known as autologous conditioned plasma.
How is PRP prepared?
A sample of the patient's blood is centrifuged so that the platelets are concentrated. This platelet concentrate is then injected into the tissue where stimulation is desired.
How is PRP used for hair loss?
PRP contains growth factors and cytokines that can stimulate soft tissue. In dermatology it is used for androgenic alopecia, or pattern hair loss, by injecting the platelet concentrate into the scalp.
Is PRP made from my own blood?
Yes. PRP is autologous, meaning it is prepared from the patient's own blood. This is relevant to its safety profile.
Does PRP definitely work for hair loss?
The evidence is mixed. As of 2020, PRP had been shown to be effective in certain conditions and ineffective in others, so its benefit should be viewed with that uncertainty in mind rather than as an established certainty.
What adverse effects did systematic reviews report for PRP in hair loss?
A 2023 Blood Transfusion systematic review and meta-analysis of PRP for alopecia (AGA, androgenetic alopecia; AA, alopecia areata) reported: "There were no serious adverse events related to PRP injection or control treatments." A 2020 Journal of Cosmetic Dermatology systematic review of randomised trials of PRP in pattern hair loss reported: "We did not identify serious treatment-related adverse events."
What did the Blood Transfusion meta-analysis report for alopecia areata?
A 2023 Blood Transfusion systematic review and meta-analysis of PRP for alopecia (AGA, androgenetic alopecia; AA, alopecia areata) reported: "In individuals with AA, it is unclear whether PRP injection compared with triamcinolone injection increase the rate of subjects with hair regrowth (very-low quality of evidence due to inconsistency, imprecision, and risk of bias)."
Conditions treated
Clinical conditions for which prp for hair loss is a treatment-ladder option.
Related Procedures
Other hair transplant procedures in our registry